CPC C07C 309/26 (2013.01) [A61P 25/28 (2018.01); C07C 309/19 (2013.01); C07C 309/27 (2013.01); C07C 317/50 (2013.01); C07C 323/59 (2013.01); C07C 323/60 (2013.01); C07D 207/14 (2013.01); C07D 207/16 (2013.01); C07D 209/20 (2013.01); C07D 211/58 (2013.01); C07D 233/26 (2013.01); C07D 295/185 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07K 5/00 (2013.01); C07K 5/06165 (2013.01); C07B 2200/07 (2013.01); C07C 2601/08 (2017.05); C07C 2601/14 (2017.05)] | 7 Claims |
1. A compound having the structural formula (IV-1):
![]() or a pharmaceutically acceptable salt thereof, wherein
Rb1 is selected from hydrogen, —(CH2)1-3—C(O) OH, —(CH2)1-3—C(O)O(C1-C3 alkyl), —C(O)—[CH(RA)]1-2—NH—RB, and —C(O)—[CH(RA)]1-2—NH—C(O)—[CH(RA)]1-2—NH—RB;
each R7 and each R8 is independently selected from —H, —NH2, —NRaRb—C(O)NH2, —C(O)NRaRb, —(C(Rx)(Ry))nNH2, —(C(Rx)(Ry))n NRaRb, —(C(Ra)(Rb))nC(O)NH2, —(C(Ra)(Rb))nC(O)NRaRb, —OH, —(C(Ra)(Rb))nOH, —CO2H, —(C(Ra)(Rb))nCO2H, —SO3H, —(C(Ra)(Rb))nSO3H, deuterium, halogen, alkyl, alkoxy, alkenyl, alkynyl, cyano, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl;
each Ra is hydrogen or optionally substituted alkyl;
each Rb is selected from hydrogen, alkyl substituted with a carboxyl or a carboxylate, and an amino acid or a dipeptide, wherein the amino acid or the dipeptide is bound to the nitrogen atom in R3 through a carboxy group; or Ra and Rb are taken together to form an optionally substituted heterocyclyl;
each Rx and Ry are independently a hydrogen or a C1-C6 alkyl group
n is 1 or 2;
each RA is independently selected from hydrogen or a side group of a natural or unnatural amino acid; and
RB is selected from hydrogen and a protecting group.
|